SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 120 filers reported holding SERES THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 0.20 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,800,629 | -47.4% | 756,567 | +5.9% | 0.00% | 0.0% |
Q2 2023 | $3,421,349 | -4.8% | 714,269 | +12.7% | 0.00% | 0.0% |
Q1 2023 | $3,594,037 | +0.8% | 633,869 | -0.5% | 0.00% | 0.0% |
Q4 2022 | $3,566,629 | -10.9% | 636,898 | +2.2% | 0.00% | 0.0% |
Q3 2022 | $4,001,000 | +147.4% | 623,060 | +32.2% | 0.00% | 0.0% |
Q2 2022 | $1,617,000 | -52.9% | 471,388 | -2.2% | 0.00% | 0.0% |
Q1 2022 | $3,434,000 | -12.4% | 482,178 | +2.5% | 0.00% | 0.0% |
Q4 2021 | $3,918,000 | +20.8% | 470,292 | +0.9% | 0.00% | 0.0% |
Q3 2021 | $3,243,000 | -67.6% | 465,883 | +10.9% | 0.00% | -66.7% |
Q2 2021 | $10,021,000 | +27.3% | 420,165 | +9.9% | 0.00% | 0.0% |
Q1 2021 | $7,874,000 | -13.7% | 382,377 | +2.7% | 0.00% | -25.0% |
Q4 2020 | $9,122,000 | -6.0% | 372,308 | +8.6% | 0.00% | 0.0% |
Q3 2020 | $9,702,000 | +390.0% | 342,693 | -17.6% | 0.00% | +300.0% |
Q2 2020 | $1,980,000 | +42.3% | 415,888 | +6.8% | 0.00% | 0.0% |
Q1 2020 | $1,391,000 | +4.7% | 389,467 | +1.2% | 0.00% | 0.0% |
Q4 2019 | $1,328,000 | -13.2% | 384,909 | +0.9% | 0.00% | 0.0% |
Q3 2019 | $1,530,000 | +70.6% | 381,413 | +36.9% | 0.00% | 0.0% |
Q2 2019 | $897,000 | -3.7% | 278,550 | +105.6% | 0.00% | 0.0% |
Q1 2019 | $931,000 | +69.3% | 135,499 | +11.4% | 0.00% | – |
Q4 2018 | $550,000 | -40.9% | 121,585 | -0.7% | 0.00% | -100.0% |
Q3 2018 | $930,000 | -7.8% | 122,493 | +4.5% | 0.00% | 0.0% |
Q2 2018 | $1,009,000 | +39.2% | 117,255 | +18.8% | 0.00% | 0.0% |
Q1 2018 | $725,000 | -25.2% | 98,693 | +3.3% | 0.00% | 0.0% |
Q4 2017 | $969,000 | -41.5% | 95,534 | -7.5% | 0.00% | 0.0% |
Q3 2017 | $1,657,000 | +60.1% | 103,286 | +12.8% | 0.00% | 0.0% |
Q2 2017 | $1,035,000 | +0.8% | 91,543 | +0.5% | 0.00% | 0.0% |
Q1 2017 | $1,027,000 | +19.7% | 91,049 | +5.1% | 0.00% | 0.0% |
Q4 2016 | $858,000 | +11.4% | 86,603 | +38.3% | 0.00% | 0.0% |
Q3 2016 | $770,000 | -32.9% | 62,599 | +58.6% | 0.00% | 0.0% |
Q2 2016 | $1,147,000 | +83.8% | 39,470 | +68.0% | 0.00% | 0.0% |
Q1 2016 | $624,000 | -22.9% | 23,492 | +2.0% | 0.00% | 0.0% |
Q4 2015 | $809,000 | +74.7% | 23,033 | +47.6% | 0.00% | 0.0% |
Q3 2015 | $463,000 | – | 15,610 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Pioneering Inc. | 23,117,045 | $55,018,567 | 3.99% |
Lion Point Capital, LP | 691,803 | $1,646,491 | 0.73% |
Eversept Partners, LP | 2,352,556 | $5,599,083 | 0.47% |
Soleus Capital Management, L.P. | 1,820,983 | $4,333,940 | 0.40% |
Simplify Asset Management Inc. | 550,626 | $1,310,490 | 0.15% |
Avoro Capital Advisors LLC | 2,500,000 | $5,950,000 | 0.09% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 45,419 | $108,097 | 0.07% |
Knott David M Jr | 70,000 | $167 | 0.06% |
XTX Topco Ltd | 150,097 | $357,231 | 0.06% |
FEDERATED HERMES, INC. | 8,981,717 | $21,376,486 | 0.06% |